Molnár, P., Demény, M. Á., Várkonyi, B., Várkonyi, B., Polgár, Z., Pór, Á., . . . Szántó, M. The clinically applied PARP inhibitor talazoparib ameliorates imiquimod-induced psoriasis in mice without reducing skin inflammation. Frontiers Media S.A.
Chicago Style (17th ed.) CitationMolnár, Petra, et al. The Clinically Applied PARP Inhibitor Talazoparib Ameliorates Imiquimod-induced Psoriasis in Mice Without Reducing Skin Inflammation. Frontiers Media S.A.
MLA (9th ed.) CitationMolnár, Petra, et al. The Clinically Applied PARP Inhibitor Talazoparib Ameliorates Imiquimod-induced Psoriasis in Mice Without Reducing Skin Inflammation. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.